About the Product

Description


Spartale 200 Tablet contains Sparfloxacin 200mg, a potent broad-spectrum fluoroquinolone antibiotic used for treating moderate to severe bacterial infections. It helps in rapid elimination of infectious bacteria and supports effective infection control.

Sparfloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, preventing bacterial replication and promoting fast recovery. Its higher dosage ensures enhanced efficacy for resistant or severe infections.

This tablet is widely prescribed for patients requiring systemic antibiotic therapy, providing convenient oral administration and ensuring better compliance in prolonged treatment courses.

For PCD pharma franchise partners, Spartale 200 Tablet is a high-demand antibiotic product, available at best price for PCD pharma franchise, making it ideal for hospitals, clinics, pharmacies, and export markets. Its strong market demand and prescriber confidence make it a valuable addition to any antibiotic portfolio.

Common side effects may include nausea, vomiting, diarrhea, headache, dizziness, or mild abdominal discomfort. Rare but serious side effects include tendon rupture, QT prolongation, liver toxicity, or severe allergic reactions. Immediate medical attention should be sought if severe or persistent symptoms occur.

Spartale 200 Tablet is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other infections caused by Sparfloxacin-sensitive bacteria, as prescribed by a healthcare professional.

Spartale 200 Tablet should be taken exactly as prescribed. Avoid exposure to sunlight or UV rays, as Sparfloxacin may increase photosensitivity. Inform the doctor of any history of tendon disorders, cardiac problems, liver or kidney disease, or other medications being taken. Do not exceed the recommended dosage.

Store Spartale 200 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Sparfloxacin 200mg Tablet in the PCD pharma franchise market?

Sparfloxacin 200mg Tablet has demand in the anti-infective, respiratory care, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on antibiotic healthcare portfolios.

Why should medical distributors include Sparfloxacin 200mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for bacterial infection management under medical supervision. Sparfloxacin 200mg is a fluoroquinolone antibiotic that helps inhibit the growth of susceptible bacteria Commonly prescribed for the treatment of respiratory tract infections, community-acquired pneumonia, sinusitis, and other susceptible bacterial infections as advised by healthcare professionals Helps control bacterial growth and supports recovery from infection-related symptoms Convenient oral tablet formulation enhances patient compliance and ease of administration Frequently utilized in respiratory and general medicine practice Widely prescribed by physicians, pulmonologists, and general practitioners This strengthens a comprehensive anti-infective and respiratory care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Sparfloxacin 200mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from steady prescription demand, repeat orders, reliable supply chain support, and attractive margins in the anti-infective segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.